Accustem Sciences Inc (QB) (ACUT) Actualités

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

AccuStem Sciences, Inc. and EmeritusDX Announce Joint Product Development Agreement and Strategic Partnership

    AccuStem Sciences, Inc. and EmeritusDX Announce Joint Product Development Agreement and Strategic...

AccuStem Sciences, Inc. Extends and Broadens Partnership with Instituto Europeo di Oncologia (IEO) Enabling its Strategic Approach to Address Unanswered Clinical Questions in Early Stage Breast Cancer

 AccuStem Sciences, Inc. Extends and Broadens Partnership with Instituto Europeo di Oncologia (IEO) Enabling its Strategic Approach to...

Current Report Filing (8-k)

0001850767 false 0001850767 2023-06-05 2023-06-05 iso4217:USD xbrli:shares...

Current Report Filing (8-k)

0001850767 false 0001850767 2023-06-06 2023-06-06 iso4217:USD xbrli:shares...

Amended Annual Report (10-k/a)

0001850767 true FY 0001850767 2022-01-01 2022-12-31 0001850767...

Annual Report (10-k)

0001850767 false FY

Securities Registration Statement (s-1/a)

0001850767 true S-1/A